Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder

International Journal of Hematology

Volumn 94, Issue 5, 2011, Pages 495-498

  Shimizu, Hiroaki ^a   Saitoh, Takayuki ^b   Koya, Hiroko ^a   Yuzuriha, Akinori ^a   Hoshino, Takumi ^b   Hatsumi, Nahoko ^a   Takada, Satoru ^a   Nagaki, Tomohito ^b   Nojima, Yoshihisa ^b   Sakura, Toru ^a  

^a SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

CNS; Epstein Barr virus; Post transplant lymphoproliferative disorder

Indexed keywords

CD20 ANTIGEN; CD79A ANTIGEN; CYTARABINE; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; FLUDARABINE; HLA ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROTEIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW BIOPSY; BRAIN EDEMA; BRAIN RADIATION; CANCER INVASION; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CELL NUCLEUS INCLUSION BODY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; COMA; CRANIOTOMY; DECOMPRESSION SURGERY; DNA REPLICATION; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATURIA; HEMISPHERE; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; ISOLATED CENTRAL NERVOUS SYSTEM POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MITOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PROTEIN CEREBROSPINAL FLUID LEVEL; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR CELL; TUMOR REGRESSION; UMBILICAL CORD BLOOD; VIRUS LOAD;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BRAIN DISEASES; DNA, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOPROLIFERATIVE DISORDERS; RADIOTHERAPY; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84355162109     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0951-3     Document Type: Article

References (20)

1. RS Shapiro K McClain G Frizzera KJ Gajl-Peczalska JH Kersey BR Blazar, et al. 1988 Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 71 5 1234 1243 2833957 1:STN:280:DyaL1c7ptlentw%3D%3D
2. J Styczynski P Reusser H Einsele R de la Camara C Cordonnier KN Ward, et al. 2009 Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia Bone Marrow Transplant 43 757 770 19043458 10.1038/bmt.2008.386 1:STN:280:DC%2BD1Mznt12gug%3D%3D
3. RE Curtis LB Travis PA Rowlings G Socié DW Kingma PM Banks, et al. 1999 Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study Blood 94 2208 2216 10498590 1:CAS:528: DyaK1MXmsVCis7Y%3D (Pubitemid 29467666)
4. O Landgren ES Gilbert JD Rizzo G Socié PM Banks KA Sobocinski, et al. 2009 Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation Blood 113 4992 5001 19264919 10.1182/blood-2008-09-178046 1:CAS:528:DC%2BD1MXmslalt78%3D
5. N Reddy K Rezvani AJ Barrett BN Savani 2011 Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients Biol Blood Marrow Transplant 17 591 597 20732435 10.1016/j.bbmt.2010.08.007
6. JW van Esser HG Niesters B van der Holt E Meijer AD Osterhaus JW Gratama, et al. 2002 Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation Blood 99 4364 4369 12036863 10.1182/blood.V99.12.4364 (Pubitemid 34627202)
7. DM Weinstock GG Ambrossi C Brennan TE Kiehn A Jakubowski 2006 Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development Bone Marrow Transplant 37 539 546 16462755 10.1038/sj.bmt.1705289 1:STN:280:DC%2BD287jsVyisw%3D%3D (Pubitemid 43378825)
8. I Ahmad NV Cau J Kwan Y Maaroufi N Meuleman M Aoun, et al. 2009 Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation Transplantation. 87 1240 1245 19384173 10.1097/TP.0b013e31819f1c49 1:CAS:528:DC%2BD1MXkvVSrsLY%3D
9. K Nagafuji T Eto S Hayashi K Oshima Y Maeda H Gondo, et al. 1998 Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain Bone Marrow Transplant 21 1155 1158 9645581 10.1038/sj.bmt.1701205 1:STN:280:DyaK1czgslCrug%3D%3D (Pubitemid 28256659)
10. T Terasawa H Ohashi K Tsushita M Utsumi E Mukai S Nakamura, et al. 2002 Failure to detect Epstein-Barr virus (EBV) DNA in plasma by real-time PCR in a case of EBV-associated posttransplantation lymphoproliferative disorder confined to the central nervous system Int J Hematol 75 416 420 12041675 10.1007/BF02982135 (Pubitemid 43020301)
11. S Pakakasama GM Eames MC Morriss MH Huls CM Rooney HE Heslop, et al. 2004 Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes Transplantation. 78 755 757 15371682 10.1097/01.TP.0000129813.54517.25 (Pubitemid 39244742)
12. C Nozzoli B Bartolozzi S Guidi A Orsi AM Vannucchi F Leoni, et al. 2006 Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation Leuk Lymphoma 47 167 169 16321845 10.1080/ 10428190500254208 1:STN:280:DC%2BD2MnktFWqsQ%3D%3D (Pubitemid 43101743)
13. M Hamadani LK Martin DM Benson EA Copelan SM Devine CC Hofmeister 2007 Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR Bone Marrow Transplant 39 249 251 17290281 10.1038/sj.bmt.1705575 1:CAS:528: DC%2BD2sXhsV2isbY%3D
14. Y Aisa T Mori T Nakazato S Suzuki N Suzuki Y Ikeda, et al. 2009 Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation Transpl Infect Dis 11 438 441 19497045 10.1111/j.1399-3062.2009.00409.x 1:STN:280:DC%2BD1MnmvVektQ%3D%3D
15. T Vu G Carrum G Hutton HE Heslop MK Brenner R Kamble 2007 Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant 39 705 709 17401392 10.1038/sj.bmt. 1705666 1:CAS:528:DC%2BD2sXlt1KksLo%3D (Pubitemid 46813587)
16. HE Heslop KS Slobod MA Pule GA Hale A Rousseau CA Smith, et al. 2010 Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients Blood 115 925 935 19880495 10.1182/blood-2009-08-239186 1:CAS:528:DC%2BC3cXhvFOitr0%3D
17. JW van Esser B van der Holt E Meijer HG Niesters R Trenschel SF Thijsen, et al. 2001 Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT Blood 98 972 978 11493441 10.1182/blood.V98.4.972
18. SJ Stevens EA Verschuuren I Pronk W van Der Bij MC Harmsen TH The, et al. 2001 Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients Blood 97 1165 1171 11222357 10.1182/blood.V97.5. 1165 1:CAS:528:DC%2BD3MXhs12lsbY%3D (Pubitemid 32183736)
19. A Harjunpää T Wiklund J Collan R Janes J Rosenberg D Lee, et al. 2001 Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma Leuk Lymphoma 42 731 738 11697503 10.3109/10428190109099335 (Pubitemid 32782781)
20. LL Muldoon SJ Lewin E Dósa DF Kraemer MA Pagel ND Doolittle, et al. 2011 Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma Clin Cancer Res 17 2207 2215 21385922 10.1158/1078-0432.CCR-10-2923 1:CAS:528:DC%2BC3MXkslCgsLc%3D